Received Nov 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | NA0589 | LA |
Persistent sudden bursts of very loose bowel movements to diarrhea to today (11/6/25) and perhaps beyond; This is a spontaneous report received from a Consumer or other non HCP. A female patient (not pregnant) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), on 23Sep2025 as dose 1, single (Lot number: NA0589), in left deltoid for covid-19 immunisation. The patient's relevant medical history included: "HBP" (unspecified if ongoing); "cholesterol high" (unspecified if ongoing); "low thyroid" (unspecified if ongoing); "glaucoma" (unspecified if ongoing); "Latex allergy" (unspecified if ongoing). The patient took concomitant medications. The following information was reported: DIARRHOEA (non-serious) with onset 30Oct2025, outcome "not recovered", described as "Persistent sudden bursts of very loose bowel movements to diarrhea to today (11/6/25) and perhaps beyond". Therapeutic measures were not taken as a result of diarrhoea. Additional information: It was reported that Persistent sudden bursts of very loose bowel movements to diarrhea to today (06Nov25) and perhaps beyond. the patient did not receive any other vaccines on the same date as the vaccine(s) for which you are reporting, the patient did not receive any other vaccines within 4 weeks PRIOR to the vaccine(s) for which you are reporting, the patient was taking other medications within 2 weeks of the event starting.
Medical History/Concurrent Conditions: Blood pressure high; Cholesterol high; Glaucoma; Latex allergy; Thyroid function decreased